001     140809
005     20250415113136.0
024 7 _ |a 10.1007/s00259-019-04342-3
|2 doi
024 7 _ |a pmid:31183635
|2 pmid
024 7 _ |a 0340-6997
|2 ISSN
024 7 _ |a 1432-105X
|2 ISSN
024 7 _ |a 1619-7070
|2 ISSN
024 7 _ |a 1619-7089
|2 ISSN
024 7 _ |a altmetric:61982714
|2 altmetric
037 _ _ |a DZNE-2020-07131
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hoenig, Merle C
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Level of education mitigates the impact of tau pathology on neuronal function.
260 _ _ |a Heidelberg [u.a.]
|c 2019
|b Springer-Verl.
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2019-06-10
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2019-08-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1744709456_6736
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Using PET imaging in a group of patients with Alzheimer's disease (AD), we investigated whether level of education, a proxy for resilience, mitigates the harmful impact of tau pathology on neuronal function.We included 38 patients with mild-to-moderate AD (mean age 67 ± 7 years, mean MMSE score 24 ± 4, mean years of education 14 ± 4; 20 men, 18 women) in whom a [18F]AV-1451 scan (a measure of tau pathology) and an [18F]FDG scan (a measure of neuronal function) were available. The preprocessed PET scans were z-transformed using templates for [18F]AV-1451 and [18F]FDG from healthy controls, and subsequently thresholded at a z-score of ≥3.0, representing an one-tailed p value of 0.001. Next, three volumes were computed in each patient: the tau-specific volume (tau pathology without neuronal dysfunction), the FDG-specific volume (neuronal dysfunction without tau pathology), and the overlap volume (tau pathology and neuronal dysfunction). Mean z-scores and volumes were extracted and used as dependent variables in regression analysis with years of education as predictor, and age and MMSE score as covariates.Years of education were positively associated with tau-specific volume (β = 0.362, p = 0.022), suggesting a lower impact of tau pathology on neuronal function in patients with higher levels of education. Concomitantly, level of education was positively related to tau burden in the overlap volume (β = 0.303, p = 0.036) implying that with higher levels of education more tau pathology is necessary to induce neuronal dysfunction.In patients with higher levels of education, tau pathology is less paralleled by regional and remote neuronal dysfunction. The data suggest that early life-time factors such as level of education support resilience mechanisms, which ameliorate AD-related effects later in life.
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 0
542 _ _ |i 2019-06-10
|2 Crossref
|u http://www.springer.com/tdm
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Alzheimer Disease: diagnostic imaging
|2 MeSH
650 _ 2 |a Alzheimer Disease: metabolism
|2 MeSH
650 _ 2 |a Alzheimer Disease: pathology
|2 MeSH
650 _ 2 |a Alzheimer Disease: physiopathology
|2 MeSH
650 _ 2 |a Educational Status
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Neurons: pathology
|2 MeSH
650 _ 2 |a Positron-Emission Tomography
|2 MeSH
650 _ 2 |a tau Proteins: metabolism
|2 MeSH
700 1 _ |a Bischof, Gérard N
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Onur, Özgür A
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Kukolja, Juraj
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Jessen, Frank
|0 P:(DE-2719)2000032
|b 4
|u dzne
700 1 _ |a Fliessbach, Klaus
|0 P:(DE-2719)2811326
|b 5
|u dzne
700 1 _ |a Neumaier, Bernd
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Fink, Gereon R
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Kalbe, Elke
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Drzezga, Alexander
|0 P:(DE-2719)2811239
|b 9
|u dzne
700 1 _ |a Eimeren, Thilo
|0 P:(DE-2719)2812285
|b 10
|e Last author
|u dzne
700 1 _ |a Initiative, Alzheimer’s Disease Neuroimaging
|0 P:(DE-HGF)0
|b 11
773 1 8 |a 10.1007/s00259-019-04342-3
|b : Springer Science and Business Media LLC, 2019-06-10
|n 9
|p 1787-1795
|3 journal-article
|2 Crossref
|t European Journal of Nuclear Medicine and Molecular Imaging
|v 46
|y 2019
|x 1619-7070
773 _ _ |a 10.1007/s00259-019-04342-3
|g Vol. 46, no. 9, p. 1787 - 1795
|0 PERI:(DE-600)2098375-X
|n 9
|q 46:9<1787 - 1795
|p 1787-1795
|t European journal of nuclear medicine and molecular imaging
|v 46
|y 2019
|x 1619-7070
856 4 _ |u https://pub.dzne.de/record/140809/files/DZNE-2020-07131_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/140809/files/DZNE-2020-07131_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:140809
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2000032
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2811326
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2811239
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2812285
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2019
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NUCL MED MOL I : 2021
|d 2022-11-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-23
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-23
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2022-11-23
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b EUR J NUCL MED MOL I : 2021
|d 2022-11-23
920 1 _ |0 I:(DE-2719)1011102
|k AG Jessen
|l Clinical Alzheimer’s Disease Research
|x 0
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies (Bonn)
|l Patient Studies (Bonn)
|x 1
920 1 _ |0 I:(DE-2719)1011202
|k AG Boecker
|l Positron Emissions Tomography (PET)
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1011102
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1011202
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(09)70299-6
|2 Crossref
|o 10.1016/S1474-4422(09)70299-6
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/aww027
|2 Crossref
|o 10.1093/brain/aww027
999 C 5 |9 -- missing cx lookup --
|a 10.1002/acn3.339
|2 Crossref
|o 10.1002/acn3.339
999 C 5 |9 -- missing cx lookup --
|a 10.1126/scitranslmed.aaf2362
|2 Crossref
|o 10.1126/scitranslmed.aaf2362
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awx243
|2 Crossref
|o 10.1093/brain/awx243
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2018.02.020
|2 Crossref
|o 10.1016/j.jalz.2018.02.020
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-160316
|2 Crossref
|o 10.3233/JAD-160316
999 C 5 |9 -- missing cx lookup --
|a 10.1017/S1355617702813248
|2 Crossref
|o 10.1017/S1355617702813248
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2018.07.219
|2 Crossref
|o 10.1016/j.jalz.2018.07.219
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s11682-016-9566-x
|2 Crossref
|o 10.1007/s11682-016-9566-x
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tics.2012.04.005
|2 Crossref
|o 10.1016/j.tics.2012.04.005
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2017.05.004
|2 Crossref
|o 10.1016/j.neurobiolaging.2017.05.004
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0000000000005303
|2 Crossref
|o 10.1212/WNL.0000000000005303
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(12)70291-0
|2 Crossref
|o 10.1016/S1474-4422(12)70291-0
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2011.03.005
|2 Crossref
|o 10.1016/j.jalz.2011.03.005
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12021-014-9235-4
|2 Crossref
|o 10.1007/s12021-014-9235-4
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neurobiolaging.2017.06.016
|2 Crossref
|o 10.1016/j.neurobiolaging.2017.06.016
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneur.65.11.1467
|2 Crossref
|o 10.1001/archneur.65.11.1467
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.jalz.2012.01.009
|2 Crossref
|o 10.1016/j.jalz.2012.01.009
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awu035
|2 Crossref
|o 10.1093/brain/awu035
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.21212
|2 Crossref
|o 10.1002/ana.21212
999 C 5 |9 -- missing cx lookup --
|a 10.1001/archneurol.2012.510
|2 Crossref
|o 10.1001/archneurol.2012.510
999 C 5 |9 -- missing cx lookup --
|a 10.1037/0894-4105.19.2.181
|2 Crossref
|o 10.1037/0894-4105.19.2.181
999 C 5 |9 -- missing cx lookup --
|a 10.1097/PSY.0b013e31820573b6
|2 Crossref
|o 10.1097/PSY.0b013e31820573b6
999 C 5 |9 -- missing cx lookup --
|a 10.1093/geront/47.3.307
|2 Crossref
|o 10.1093/geront/47.3.307
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.bbi.2012.08.014
|2 Crossref
|o 10.1016/j.bbi.2012.08.014
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awq185
|2 Crossref
|o 10.1093/brain/awq185
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2012.08.019
|2 Crossref
|o 10.1016/j.neuron.2012.08.019
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0014-4886(73)90090-3
|2 Crossref
|o 10.1016/0014-4886(73)90090-3
999 C 5 |9 -- missing cx lookup --
|a 10.1073/pnas.97.23.12880
|2 Crossref
|o 10.1073/pnas.97.23.12880
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S0165-3806(02)00642-9
|2 Crossref
|o 10.1016/S0165-3806(02)00642-9
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuroscience.2006.09.057
|2 Crossref
|o 10.1016/j.neuroscience.2006.09.057
999 C 5 |9 -- missing cx lookup --
|a 10.1016/0165-3806(89)90068-0
|2 Crossref
|o 10.1016/0165-3806(89)90068-0
999 C 5 |9 -- missing cx lookup --
|a 10.1001/jamaneurol.2018.1836
|2 Crossref
|o 10.1001/jamaneurol.2018.1836
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1460-9568.2005.04290.x
|2 Crossref
|o 10.1111/j.1460-9568.2005.04290.x
999 C 5 |9 -- missing cx lookup --
|a 10.1177/1073858407305850
|2 Crossref
|o 10.1177/1073858407305850
999 C 5 |9 -- missing cx lookup --
|a 10.1001/jamaneurol.2014.4761
|2 Crossref
|o 10.1001/jamaneurol.2014.4761
999 C 5 |9 -- missing cx lookup --
|a 10.1212/WNL.0000000000000382
|2 Crossref
|o 10.1212/WNL.0000000000000382
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-180179
|2 Crossref
|o 10.3233/JAD-180179
999 C 5 |9 -- missing cx lookup --
|a 10.1523/JNEUROSCI.5791-12.2015
|2 Crossref
|o 10.1523/JNEUROSCI.5791-12.2015
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.nbd.2011.04.022
|2 Crossref
|o 10.1016/j.nbd.2011.04.022
999 C 5 |9 -- missing cx lookup --
|a 10.1093/hmg/ddp367
|2 Crossref
|o 10.1093/hmg/ddp367
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1460-9568.2008.06084.x
|2 Crossref
|o 10.1111/j.1460-9568.2008.06084.x
999 C 5 |9 -- missing cx lookup --
|a 10.1002/ana.410440706
|2 Crossref
|o 10.1002/ana.410440706
999 C 5 |9 -- missing cx lookup --
|a 10.3233/JAD-2006-9S305
|2 Crossref
|o 10.3233/JAD-2006-9S305
999 C 5 |9 -- missing cx lookup --
|a 10.1093/cercor/bhy078
|2 Crossref
|o 10.1093/cercor/bhy078
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s12264-013-1414-z
|2 Crossref
|o 10.1007/s12264-013-1414-z


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21